KD Logo

Quest Diagnostics, Inc [DGX] SVP & General Counsel makes an insider purchase of 35,146 shares worth 5.73 million.

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Quest Diagnostics, Inc shares valued at $5,731,302 were sold by PREVOZNIK MICHAEL E on Nov 29 ’24. At $163.07 per share, PREVOZNIK MICHAEL E sold 35,146 shares. The insider’s holdings dropped to 38,478 shares worth approximately $5.83 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Doherty Catherine T. sold 33,103 shares, netting a total of over 5,395,484 in proceeds. Following the sale of shares at $162.99 each, the insider now holds 68,412 shares.

Before that, PREVOZNIK MICHAEL E had added 35,146 shares to its account. In a trade valued at $5,731,302, the Officer bought Quest Diagnostics, Inc shares for $163.07 each.

As published in a research note from Morgan Stanley on December 17, 2024, Quest Diagnostics, Inc [DGX] has been rated up from an Equal-weight to an Overweight and the price target has been revised to $172 from $145. As of October 23, 2024, Robert W. Baird has increased its “Neutral” rating to a “an Outperform” for DGX.

Analyzing DGX Stock Performance

During the last five days, there has been a drop of approximately -2.92%. Over the course of the year, Quest Diagnostics, Inc shares have jumped approximately 9.89%. Shares of the company reached a 52-week high of $165.32 on 11/25/24 and a 52-week low of $123.04 on 02/01/24. A 50-day SMA is recorded $156.62, while a 200-day SMA reached $145.68. Nevertheless, trading volume fell to 1.08 million shares from 0.97 million shares the previous day.

Support And Resistance Levels for Quest Diagnostics, Inc (DGX)

According to the 24-hour chart, there is a support level at 149.53, which, if violated, would cause prices to drop to 147.54. In the upper region, resistance lies at 153.05. The next price resistance is at 154.57. RSI (Relative Strength Index) is 36.08 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -3.95, which suggests the price will decrease in the coming days. Percent R is at 82.35%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular